Amit Lahoti

1.4k total citations
21 papers, 943 citations indexed

About

Amit Lahoti is a scholar working on Pulmonary and Respiratory Medicine, Nephrology and Oncology. According to data from OpenAlex, Amit Lahoti has authored 21 papers receiving a total of 943 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 6 papers in Nephrology and 6 papers in Oncology. Recurrent topics in Amit Lahoti's work include Acute Kidney Injury Research (4 papers), Renal cell carcinoma treatment (3 papers) and Eosinophilic Disorders and Syndromes (3 papers). Amit Lahoti is often cited by papers focused on Acute Kidney Injury Research (4 papers), Renal cell carcinoma treatment (3 papers) and Eosinophilic Disorders and Syndromes (3 papers). Amit Lahoti collaborates with scholars based in United States, Italy and South Korea. Amit Lahoti's co-authors include Abdulla K. Salahudeen, Pankaj Shah, Simit Doshi, Xiudong Lei, Gul Nowshad, Tushar Pawar, Jörge E. Cortes, Hagop M. Kantarjian, Ala Abudayyeh and Susan O’Brien and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer.

In The Last Decade

Amit Lahoti

19 papers receiving 929 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amit Lahoti United States 13 382 306 279 205 168 21 943
Raoul Bergner Germany 19 352 0.9× 208 0.7× 347 1.2× 103 0.5× 171 1.0× 80 1.1k
Rikako Hiramatsu Japan 20 262 0.7× 559 1.8× 132 0.5× 115 0.6× 278 1.7× 104 1.2k
Roberta Fenoglio Italy 19 297 0.8× 374 1.2× 56 0.2× 123 0.6× 159 0.9× 89 997
Phuong‐Thu T. Pham United States 16 196 0.5× 208 0.7× 85 0.3× 143 0.7× 132 0.8× 31 1.0k
Claire Presne France 15 163 0.4× 508 1.7× 59 0.2× 167 0.8× 126 0.8× 37 964
Douglas Briggs United Kingdom 6 271 0.7× 361 1.2× 219 0.8× 65 0.3× 128 0.8× 6 992
Morton Kleiner United States 15 140 0.4× 319 1.0× 101 0.4× 236 1.2× 70 0.4× 21 797
Nada Alachkar United States 23 260 0.7× 907 3.0× 120 0.4× 78 0.4× 147 0.9× 56 1.8k
Miquel Blasco Spain 18 138 0.4× 410 1.3× 52 0.2× 129 0.6× 90 0.5× 64 767
Ángel Sevillano Spain 18 115 0.3× 391 1.3× 63 0.2× 91 0.4× 187 1.1× 48 883

Countries citing papers authored by Amit Lahoti

Since Specialization
Citations

This map shows the geographic impact of Amit Lahoti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amit Lahoti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amit Lahoti more than expected).

Fields of papers citing papers by Amit Lahoti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amit Lahoti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amit Lahoti. The network helps show where Amit Lahoti may publish in the future.

Co-authorship network of co-authors of Amit Lahoti

This figure shows the co-authorship network connecting the top 25 collaborators of Amit Lahoti. A scholar is included among the top collaborators of Amit Lahoti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amit Lahoti. Amit Lahoti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mamlouk, Omar, Umut Selamet, Maen Abdelrahim, et al.. (2019). Nephrotoxicity of immune checkpoint inhibitors beyond tubulointerstitial nephritis: single-center experience. Journal for ImmunoTherapy of Cancer. 7(1). 2–2. 199 indexed citations
2.
3.
Abudayyeh, Ala, Maen Abdelrahim, Umut Selamet, et al.. (2018). Checkpoint inhibitor induced glomerulonephritis.. Journal of Clinical Oncology. 36(15_suppl). e15083–e15083. 3 indexed citations
4.
5.
Cortes, Jörge E., Carlo Gambacorti‐Passerini, Dong‐Wook Kim, et al.. (2017). Effects of Bosutinib Treatment on Renal Function in Patients With Philadelphia Chromosome-Positive Leukemias. Clinical Lymphoma Myeloma & Leukemia. 17(10). 684–695.e6. 40 indexed citations
6.
Doshi, Mona, et al.. (2016). Paraprotein–Related Kidney Disease: Kidney Injury from Paraproteins—What Determines the Site of Injury?. Clinical Journal of the American Society of Nephrology. 11(12). 2288–2294. 55 indexed citations
7.
Sasaki, Koji, Amit Lahoti, Elias Jabbour, et al.. (2015). Clinical Safety and Efficacy of Nilotinib or Dasatinib in Patients With Newly Diagnosed Chronic-Phase Chronic Myelogenous Leukemia and Pre-Existing Liver and/or Renal Dysfunction. Clinical Lymphoma Myeloma & Leukemia. 16(3). 152–162. 26 indexed citations
8.
Yılmaz, Musa, Amit Lahoti, Susan O’Brien, et al.. (2015). Estimated glomerular filtration rate changes in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors. Cancer. 121(21). 3894–3904. 57 indexed citations
9.
Abudayyeh, Ala, Amit Lahoti, & Abdulla K. Salahudeen. (2014). Onconephrology: the need and the emergence of a subspecialty in nephrology. Kidney International. 85(5). 1002–1004. 21 indexed citations
10.
Saunders, Ila M., et al.. (2014). Topical cidofovir–induced acute kidney injury in two severely immunocompromised patients with refractory multidrug-resistant herpes simplex virus infections. Journal of Oncology Pharmacy Practice. 22(2). 325–331. 11 indexed citations
11.
12.
Escalante, Carmelita P., Amit Lahoti, Shana L. Palla, et al.. (2013). Practice patterns of bevacizumab-induced hypertension in cancer patients.. Journal of Clinical Oncology. 31(15_suppl). e20664–e20664. 1 indexed citations
13.
14.
Salahudeen, Abdulla K., Simit Doshi, Tushar Pawar, et al.. (2012). Incidence Rate, Clinical Correlates, and Outcomes of AKI in Patients Admitted to a Comprehensive Cancer Center. Clinical Journal of the American Society of Nephrology. 8(3). 347–354. 124 indexed citations
15.
Doshi, Simit, Pankaj Shah, Xiudong Lei, Amit Lahoti, & Abdulla K. Salahudeen. (2011). Hyponatremia in Hospitalized Cancer Patients and Its Impact on Clinical Outcomes. American Journal of Kidney Diseases. 59(2). 222–228. 164 indexed citations
16.
Gulbis, Alison, Catherine M. Bollard, Ann M. Leen, et al.. (2011). Evaluation and Management of BK Virus-Associated Nephropathy Following Allogeneic Hematopoietic Cell Transplantation. Biology of Blood and Marrow Transplantation. 17(11). 1589–1593. 11 indexed citations
17.
Lahoti, Amit, Joseph L. Nates, Chris Wakefield, Kristen Price, & Abdulla K. Salahudeen. (2011). Costs and Outcomes of Acute Kidney Injury in Critically Ill Patients with Cancer. PubMed. 9(4). 149–155. 27 indexed citations
18.
Lahoti, Amit, Hagop M. Kantarjian, Abdulla K. Salahudeen, et al.. (2010). Predictors and outcome of acute kidney injury in patients with acute myelogenous leukemia or high‐risk myelodysplastic syndrome. Cancer. 116(17). 4063–4068. 80 indexed citations
19.
Salahudeen, Abdulla K., Vikas Kumar, Lianchun Xiao, et al.. (2009). Sustained Low Efficiency Dialysis in the Continuous Mode (C-SLED). Clinical Journal of the American Society of Nephrology. 4(8). 1338–1346. 30 indexed citations
20.
Amjad, Ali Imran, Rima M. Saliba, Syed Mohammad Ali Kazmi, et al.. (2009). Autologous Hematopoietic Stem Cell Transplantation May Reverse Renal Failure in Patients with Multiple Myeloma. Biology of Blood and Marrow Transplantation. 15(7). 812–816. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Raoul Bergner Breakdown of academic impact, for papers by Rikako Hiramatsu Breakdown of academic impact, for papers by Roberta Fenoglio Breakdown of academic impact, for papers by Phuong‐Thu T. Pham Breakdown of academic impact, for papers by Claire Presne Breakdown of academic impact, for papers by Douglas Briggs Breakdown of academic impact, for papers by Morton Kleiner Breakdown of academic impact, for papers by Nada Alachkar Breakdown of academic impact, for papers by Miquel Blasco Breakdown of academic impact, for papers by Ángel Sevillano
Rankless by CCL
2026